ANDA 85909, held by Lannett. Secobarbital Sodium.
As of Nov 15, 2026, ANDA 85909 (Secobarbital Sodium), held by Lannett, was first approved by FDA on Jun 8, 1978, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 8, 1978 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Secobarbital Sodium50MG ยท capsule;oral | Secobarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
